Trigeminal neuralgia is a chronic neuropathic pain disorder characterized by recurrent episodes of severe, sudden, electric shock-like facial pain along the distribution of the trigeminal nerve. It is considered one of the most painful neurological conditions and can significantly impair quality of life. The condition commonly affects individuals above 50 years of age and is often associated with neurovascular compression of the trigeminal nerve root.
We present the case of a 56-year-old female who presented with recurrent episodes of severe right-sided facial pain involving the maxillary and mandibular divisions of the trigeminal nerve. The pain was triggered by chewing, speaking, and brushing teeth. Neurological examination was otherwise normal. MRI brain with trigeminal nerve protocol excluded secondary causes and demonstrated vascular compression of the trigeminal nerve. The patient was treated with carbamazepine with significant symptomatic improvement.
This case highlights the importance of early recognition of trigeminal neuralgia, differentiation from dental and other facial pain disorders, and timely initiation of appropriate therapy to improve patient outcomes and quality of life.
Trigeminal neuralgia (TN), also known as tic douloureux, is a neuropathic pain syndrome involving the fifth cranial nerve. The disorder is characterized by sudden, unilateral, recurrent episodes of severe facial pain lasting from a few seconds to minutes. The pain is commonly described as stabbing, lancinating, or electric shock-like.
The trigeminal nerve provides sensory innervation to the face through three divisions:
Trigeminal neuralgia most commonly affects the maxillary and mandibular divisions. The condition is usually unilateral and rarely bilateral.
The most common mechanism involves vascular compression at the trigeminal nerve root entry zone, resulting in focal demyelination and abnormal neuronal excitability. Secondary causes include multiple sclerosis, tumors, vascular malformations, and cerebellopontine angle lesions.
The annual incidence of trigeminal neuralgia is estimated to be approximately 4–13 cases per 100,000 individuals, with a higher prevalence among females and older adults.
Patients often experience severe pain triggered by otherwise harmless activities such as:
Prompt diagnosis and early treatment are essential to reduce morbidity and improve quality of life.
Patient History
A 56-year-old female presented to the neurology outpatient department with:

The patient reported progressive worsening in frequency and severity of pain episodes.
There was no history of:
Medical history revealed:
Family history was non-contributory.
Neurological Examination
Cranial Nerve Examination
Motor Examination
Cerebellar Examination
Meningeal Signs
Based on history and examination, the following conditions were considered:
The characteristic episodic electric shock-like pain with trigger zones strongly suggested trigeminal neuralgia.

Routine Laboratory Tests
MRI Brain with Trigeminal Nerve Protocol

Findings included:
Dental Evaluation
Based on clinical features and imaging findings, a diagnosis of:
Classical Trigeminal Neuralgia involving the right maxillary (V2) and mandibular (V3) divisions
was established.
The goals of management included:
Medical Management
The patient was started on:

Clinical Course
At 1 Week
At 1 Month
At 3 Months

Pathophysiology
Trigeminal neuralgia commonly results from vascular compression of the trigeminal nerve root by adjacent arteries or veins. Chronic pulsatile compression leads to focal demyelination and hyperexcitability of trigeminal sensory fibers.
This results in:
Secondary trigeminal neuralgia may occur due to:
Epidemiology
Clinical Manifestations
Typical Symptoms
Trigger Factors
Commonly Involved Divisions
Important diagnostic tools include:
MRI is important to identify secondary causes and vascular compression.
First-line medications include:
Other agents:
Surgical Options
Indicated in refractory cases:
Microvascular decompression provides long-term pain relief in selected patients.
Complications
Potential complications include:
Untreated trigeminal neuralgia can significantly impair psychosocial functioning.
The prognosis depends on:
Most patients initially respond well to carbamazepine therapy. Surgical interventions offer favorable outcomes in medically refractory cases.
In this case, early treatment resulted in substantial symptomatic improvement and restoration of daily functioning.
Trigeminal neuralgia is a severely painful neuropathic facial pain disorder that requires prompt recognition and appropriate management. This case emphasizes the importance of identifying characteristic clinical features such as unilateral electric shock-like facial pain and trigger zones.
MRI evaluation is essential to exclude secondary causes and identify neurovascular compression. Early initiation of anticonvulsant therapy can significantly improve symptoms and quality of life.
Comprehensive clinical evaluation and individualized treatment remain the cornerstone of effective management in trigeminal neuralgia.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
On all CAR-T products, the FDA is calling for a new boxed warning.
2.
A study has developed molecular markers that predict meningioma recurrence.
3.
Brexpiprazole Safe, Effective in Early-Episode Schizophrenia
4.
AI can identify women at risk of breast cancer years in advance: Study
5.
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?
1.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
2.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
3.
Unlocking the Immune Arsenal: A Revolution in Cancer Treatment
4.
The Growing Crisis of Aplastic Anemia: A Call for Action
5.
Interpreting Iron Studies: What Your Blood Results Really Mean
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation